David Shaw’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-259,796
| Closed | -$56.4M | – | 5180 |
|
|
2021
Q1 | $56.4M | Buy |
+259,796
| New | +$48.8M | 0.05% | 432 |
|
|
2020
Q4 | – | Sell |
-8,287
| Closed | -$928K | – | 4275 |
|
|
2020
Q3 | $807K | Sell |
8,287
-3,188
| -28% | -$367K | ﹤0.01% | 2979 |
|
|
2020
Q2 | $1.41M | Sell |
11,475
-1,225
| -10% | -$139K | ﹤0.01% | 2678 |
|
|
2020
Q1 | $1.11M | Sell |
12,700
-21,128
| -62% | -$2.24M | ﹤0.01% | 2655 |
|
|
2019
Q4 | $3.54M | Buy |
33,828
+25,744
| +318% | +$2.89M | ﹤0.01% | 2020 |
|
|
2019
Q3 | $930K | Buy |
+8,084
| New | +$1.23M | ﹤0.01% | 2866 |
|
|
2019
Q2 | – | Sell |
-119,756
| Closed | -$20.7M | – | 3973 |
|
|
2019
Q1 | $20.2M | Buy |
119,756
+97,525
| +439% | +$14.5M | 0.03% | 722 |
|
|
2018
Q4 | $2.17M | Sell |
22,231
-44,964
| -67% | -$5.9M | ﹤0.01% | 2091 |
|
|
2018
Q3 | $11.6M | Buy |
67,195
+54,036
| +411% | +$7.79M | 0.01% | 1042 |
|
|
2018
Q2 | $1.84M | Buy |
+13,159
| New | +$1.87M | ﹤0.01% | 2287 |
|
|
2017
Q3 | – | Sell |
-2,503
| Closed | -$268K | – | 3679 |
|
|
2017
Q2 | $251K | Sell |
2,503
-35,456
| -93% | -$3.82M | ﹤0.01% | 3099 |
|
|
2017
Q1 | $4.59M | Sell |
37,959
-136,540
| -78% | -$16.7M | 0.01% | 1357 |
|
|
2016
Q4 | $19.5M | Buy |
174,499
+134,545
| +337% | +$16.2M | 0.03% | 633 |
|
|
2016
Q3 | $5.3M | Buy |
39,954
+9,163
| +30% | +$876K | 0.01% | 1261 |
|
|
2016
Q2 | $2.82M | Buy |
30,791
+18,661
| +154% | +$1.57M | 0.01% | 1682 |
|
|
2016
Q1 | $875K | Buy |
+12,130
| New | +$665K | ﹤0.01% | 2440 |
|
|
2015
Q4 | – | Sell |
-22,731
| Closed | -$1.85M | – | 4037 |
|
|
2015
Q3 | $2.08M | Sell |
22,731
-752
| -3% | -$83.6K | ﹤0.01% | 2073 |
|
|
2015
Q2 | $2.88M | Buy |
23,483
+13,754
| +141% | +$1.56M | ﹤0.01% | 1904 |
|
|
2015
Q1 | $887K | Buy |
+9,729
| New | +$790K | ﹤0.01% | 2657 |
|
|
2014
Q4 | – | Sell |
-14,799
| Closed | -$1.08M | – | 4354 |
|
|
2014
Q3 | $1.2M | Buy |
14,799
+11,899
| +410% | +$1.05M | ﹤0.01% | 2660 |
|
|
2014
Q2 | $311K | Buy |
+2,900
| New | +$202K | ﹤0.01% | 3820 |
|
Other funds holding GWPH
David Shaw's GWPH Position: Q2 2021 in Review
David Shaw sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 259,796 shares — an estimated $56.4M sold.
David Shaw first reported a position in GWPH in Q2 2014 and held it in 21 quarters. The position peaked at $56.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- David Shaw reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- David Shaw sold 259,796 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $56.4M.
- David Shaw first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and held it in 21 quarters.
- David Shaw's GW Pharmaceuticals Plc American Depositary Shares position peaked at $56.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on D.E. Shaw & Co's 13F filing for Q2 2021, filed 16 Aug 2021.